IDEV · iShares Core MSCI International Developed Markets ETF
IDEV tracks the Core MSCI International Developed Markets and returned +18.7% over the past year.
Key facts
Its ten largest equity positions
| Holding | Weight | |
|---|---|---|
| ASML Holding N.V. | 1.95% | |
| HSBC HOLDINGS PLC | 1.09% | |
| ASTRAZENECA PLC | 1.02% | |
| Roche Holding AG | 0.99% | |
| Novartis AG | 0.97% | |
| SHELL PLC | 0.90% | |
| Nestle S.A. | 0.90% | |
| ROYAL BANK OF CANADA | 0.87% | |
| Siemens Aktiengesellschaft | 0.78% | |
| COMMONWEALTH BANK OF AUSTRALIA | 0.73% |
Compare IDEV
Also against BINC, BITO, BND, BNDX, BOND, BOXX, BSV, BWET, CGBL, CGDV, CGGR, COWZ, CTA, DBMF, DFUS, DGRO, DGRW, DIA, DVY, DYNF, EDV, EEM, EFA, EMB, EMXC, EWJ, EWT, EWY, EWZ, EZU, FBCG, FDVV, FENI, FLKR, FNDX, FTEC, FXI, GARP, GLD, GLDM, GOVT, GRNY, HDV, HGER, HYG, HYMB, IALT, IAU, IBB, IEF, IEFA, IEI, IEMG, IGIB, IGM, IGSB, IJH, IJR, IJS, IJT, ILF, INDA, ITOT, IUSB, IVV, IWB, IWC, IWD, IWF, IWM, IWO, IXUS, IYE, IYR, IYW, JAAA, JNK, KRE, LQD, MAGS, MBB, MDY, MGK, MINT, MOAT, MTUM, MUB, NOBL, ONEQ, PDBC, PFF, PULS, PVAL, QQQ, QQQM, QUAL, RDVY, RSP, SCHB, SCHD, SCHF, SCHG, SCHH, SCHP, SCHX, SDY, SGOV, SHV, SHY, SIVR, SLV, SPHD, SPHQ, SPLG, SPMO, SPSB, SPY, SPYD, SPYG, TIP, TLT, URTH, USFR, USHY, USMV, USO, VB, VBIL, VBK, VBR, VCIT, VCLT, VCSH, VDC, VDE, VEA, VEU, VGIT, VGK, VGLT, VGSH, VGT, VHT, VIG, VLUE, VNQ, VO, VOE, VONG, VOO, VOOG, VOX, VPL, VPU, VT, VTEB, VTI, VTIP, VTV, VTWO, VUG, VUSB, VWO, VXF, VXUS, VYM, VYMI, XBI, XHB, XLB, XLC, XLE, XLF, XLG, XLI, XLK, XLP, XLRE, XLU, XLV, XLY, XOP, XOVR, XRT.
Period by period
| Window | Total return | S&P 500 | Gap to S&P 500 | Gap to Nasdaq-100 |
|---|---|---|---|---|
| 3 months | +3.2% | +3.3% | −0.1 pts | +4.0 pts |
| 6 months | +12.3% | +16.0% | −3.7 pts | −8.4 pts |
| 1 year | +18.7% | +17.5% | +1.2 pts | −4.3 pts |
| 3 years | +68.8% | +77.9% | −9.1 pts | −26.3 pts |
| Since listing | +137.6% | +277.8% | −140.2 pts | −346.4 pts |
In plain words
IDEV is an index equity fund tracking the Core MSCI International Developed Markets. Over the year to Sep 11, 2026 it returned +18.7% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.04% a year. By its holdings filed for Apr 30, 2026, 0% of the fund by weight is stocks the S&P 500 also holds, across 2268 positions, with the top ten at 10.2%.
| What it tracks | Core MSCI International Developed Markets |
|---|---|
| Fund type | Index equity fund |
| Expense ratio (485BPOS XBRL, Nov 21, 2025) | 0.04% |
| Price | $91.88 |
| Listed since | Mar 23, 2017 |
| Net assets (SEC filing, whole fund, as filed for Apr 30, 2026) | $29.4bn |
| Below its high (ETFIQ) | −2.1% |
| Holdings | 2268 |
| Top ten weight | 10.2% |
| Holdings as of (SEC N-PORT) | Apr 30, 2026 |
| Already in the S&P 500, by weight (ETFIQ) | 0.1% |
| Active share vs the S&P 500 (ETFIQ) | 100.0% |
| Already in the Nasdaq-100, by weight (ETFIQ) | 2.7% |
Questions people ask
- How has IDEV performed?
- Over the year to Sep 11, 2026, IDEV returned +18.7% with distributions reinvested, against +17.5% for the S&P 500. Over three years the figure is +68.8%.
- What does IDEV cost?
- The prospectus expense ratio is 0.04% a year.
- What does IDEV hold?
- 2268 positions as filed for Apr 30, 2026, with the top ten at 10.2% of the fund. 0% of its weight is in stocks the S&P 500 also holds.
- How far is IDEV below its high?
- 2.1% below its high of Aug 25, 2026, measured on the reinvested series to Sep 11, 2026.
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Funds near this one
Cite this page. ETFIQ, IDEV, core index fund, data as of Sep 11, 2026. https://etfiq.com/funds/IDEV Free to use with attribution; the underlying files are at Open data.
ETFIQ covers leveraged and inverse, thematic, buffer, option-income, core index and spot crypto ETFs. This fund is here because the other funds here are measured against it and portfolios hold it. ETFIQ is an independent publisher and makes no recommendations. Standards and sources